# Optimization of Infliximab Withdrawal Strategy for Rheumatoid Arthritis

> **NCT02770794** · PHASE4 · COMPLETED · sponsor: **Chiba University** · enrollment: 211 (actual)

## Conditions studied

- Arthritis, Rheumatoid

## Interventions

- **DRUG:** Infliximab

## Key facts

- **NCT ID:** NCT02770794
- **Lead sponsor:** Chiba University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-04-01
- **Primary completion:** 2020-08-14
- **Final completion:** 2020-08-14
- **Target enrollment:** 211 (ACTUAL)
- **Last updated:** 2021-01-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02770794

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02770794, "Optimization of Infliximab Withdrawal Strategy for Rheumatoid Arthritis". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02770794. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*